03:52 AM EDT, 05/01/2025 (MT Newswires) -- Guardant Health ( GH ) reported a Q1 adjusted loss late Wednesday of $0.49 per diluted share, wider than a loss of $0.46 a year earlier.

Analysts polled by FactSet expected a loss of $0.56.

Revenue for the quarter ended March 31 was $203.5 million, compared with $168.5 million a year earlier.

Analysts surveyed by FactSet expected $190.1 million.

Guardant Health ( GH ) raised its 2025 revenue guidance to be in the range of $880 million to $890 million from a prior range of $850 million to $860 million. Analysts polled by FactSet expect $866.1 million.

Shares rose nearly 4% in after-market activity Wednesday.